News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all News
Venture Capital
• Jeffrey B. Kindler - Former Chairman & CEO, Pfizer
• Prof. Konstantin G. Skryabin - Member of the Presidential Council (Russian Federation) for Science, Technology and Education
• Dr. George Poste - Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University; Regent’s Professor and Del E. Webb Distinguished Professor of Biology, Arizona State University
• Franklyn Prendergast, MD, PhD - Director, Center for Individualized Medicine, The Mayo Clinic
• Frederick Frank - Vice Chairman, Peter J. Solomon Company
• Prof. Konstantin G. Skryabin - Member of the Presidential Council (Russian Federation) for Science, Technology and Education
• Dr. George Poste - Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University; Regent’s Professor and Del E. Webb Distinguished Professor of Biology, Arizona State University
• Franklyn Prendergast, MD, PhD - Director, Center for Individualized Medicine, The Mayo Clinic
• Frederick Frank - Vice Chairman, Peter J. Solomon Company